Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ 8.24 | $ 486.33M | 1 | 58.99M |
3/31/2025 | $ 8.74 | $ 511.42M | 1 | 58.53M |
12/31/2024 | $ 9.26 | $ 538.55M | 1 | 58.15M |
9/30/2024 | $ 9.29 | $ 541.22M | 1 | 58.26M |
6/30/2024 | $ 9.32 | $ 542.52M | 1 | 58.22M |
3/31/2024 | $ 9.42 | $ 544M | 1 | 57.76M |
12/31/2023 | $ 9.5 | $ 544.91M | 1 | 57.38M |
9/30/2023 | $ 9.44 | $ 543.1M | 1 | 57.52M |
6/30/2023 | $ 9.4 | $ 539.9M | 1 | 57.45M |
3/31/2023 | $ 9.4 | $ 535.74M | 1 | 57.01M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for VANDA PHARMACEUTICALS INC is calculated as follows: Equity [ $ 440.57M ] / (Shares WA [ 54.67M ] * Share Factor [ 1 ])
(=) BVPS [ $ 8.06 ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 4K |
---|---|
min | $ -30.1 |
max | $ 46.85 |
average | $ 10.28 |
median | $ 6.03 |
std | $ 12.44 |